Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof

Details for Australian Patent Application No. 2004233851 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Houghton, Michael; O'Hagan, Derek; Singh, Manmohan

Agent FB Rice

Pub. Number AU-B-2004233851

PCT Pub. Number WO2004/096136

Priority 60/465,841 25.04.03 US

Filing date 23 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 30 July 2009

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096136 Priority application(s): WO2004/096136

18 September 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

30 July 2009 Application Accepted

  Published as AU-B-2004233851

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233852-Method of improved diuresis in individuals with impaired renal function

2004233848-Artificial valve prosthesis with improved flow dynamics